Why waiving intellectual property rights for Covid vaccines is wrong
The UK, EU and other allies should speak out against the badly thought out proposal before the WTO.
IP rights are the key to Covid-19 vaccines
The intellectual property system has continually confounded its critics in the Covid crisis, providing a framework for vaccine innovation and rapid manufacturing scale-up.
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.